Is pathologic complete remission a useful measure of response to novel therapies in neoadjuvant trials? Commentary

Alexandra Leary, Ian Smith

Résultats de recherche: Contribution à un journal › Brève enquête › Revue par des pairs

langue originale	Anglais
Pages (de - à)	126-127
Nombre de pages	2
journal	Nature Clinical Practice Oncology
Volume	3
Numéro de publication	3
Les DOIs	https://doi.org/10.1038/ncponc0447
état	Publié - 1 mars 2006
Modification externe	Oui

Accès au document

@article{8d88175b570045199f8bfa5dbd660b6e,

title = "Is pathologic complete remission a useful measure of response to novel therapies in neoadjuvant trials? Commentary",

keywords = "Breast cancer, Complete remission, Disease-free survival, Neoadjuvant, Pathologic response",

author = "Alexandra Leary and Ian Smith",

year = "2006",

month = mar,

day = "1",

doi = "10.1038/ncponc0447",

language = "English",

volume = "3",

pages = "126--127",

journal = "Nature Clinical Practice Oncology",

issn = "1743-4254",

number = "3",

}

TY - JOUR

T1 - Is pathologic complete remission a useful measure of response to novel therapies in neoadjuvant trials? Commentary

AU - Leary, Alexandra

AU - Smith, Ian

PY - 2006/3/1

Y1 - 2006/3/1

KW - Breast cancer

KW - Complete remission

KW - Disease-free survival

KW - Neoadjuvant

KW - Pathologic response

UR - http://www.scopus.com/inward/record.url?scp=33645372272&partnerID=8YFLogxK

U2 - 10.1038/ncponc0447

DO - 10.1038/ncponc0447

M3 - Short survey

AN - SCOPUS:33645372272

SN - 1743-4254

VL - 3

SP - 126

EP - 127

JO - Nature Clinical Practice Oncology

JF - Nature Clinical Practice Oncology

IS - 3

ER -